| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/22/2011 | CA2481520C Process for preparation of a sterile suspension of corticosteroid particles for administration by inhalation |
| 02/22/2011 | CA2466726C Preparation composition containing acid-unstable physiologically active compound and process for producing same |
| 02/22/2011 | CA2459857C Combinatorial type controlled release drug delivery device |
| 02/22/2011 | CA2447181C Vegetable protein-based microcapsules |
| 02/22/2011 | CA2435714C Fenofibrate tablets |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2429898C Devices and methods for cholesterol management |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/22/2011 | CA2359109C Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 02/22/2011 | CA2350882C Transfection reagents |
| 02/22/2011 | CA2170644C Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 02/18/2011 | CA2685321A1 Solubilized delivery system for topical anesthetics |
| 02/17/2011 | WO2011020054A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists |
| 02/17/2011 | WO2011020032A2 Pharmaceutical dosage form |
| 02/17/2011 | WO2011019956A2 Pharmaceutical compositions |
| 02/17/2011 | WO2011019954A2 Intracochlear drug delivery to the central nervous system |
| 02/17/2011 | WO2011019940A2 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use |
| 02/17/2011 | WO2011019819A1 Orally disintegrating compositions of linaclotide |
| 02/17/2011 | WO2011019668A1 Topical cosmeceutical formulation and methods of making and using same |
| 02/17/2011 | WO2011019414A1 Anti-viral composition and method |
| 02/17/2011 | WO2011019413A1 Pharmaceutical composition and administrations thereof |
| 02/17/2011 | WO2011019410A1 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2011 | WO2011019323A1 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents |
| 02/17/2011 | WO2011019317A1 Compositions and methods for treating fungal infection of the nail |
| 02/17/2011 | WO2011019046A1 Disintegrating particle composition and orally rapidly disintegrating tablet |
| 02/17/2011 | WO2011019045A1 Disintegrating particle composition and orally rapidly disintegrating tablet |
| 02/17/2011 | WO2011019043A1 Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles |
| 02/17/2011 | WO2011018902A1 Pharmaceutical composition for suppressing pain |
| 02/17/2011 | WO2011018858A1 Novel mastitis vaccine |
| 02/17/2011 | WO2011018801A2 Solid oral dosage form of ziprasidone |
| 02/17/2011 | WO2011018800A2 A novel in-situ gel forming solution for ocular drug delivery |
| 02/17/2011 | WO2011018583A2 Novel pharmaceutical formulations against drug misuse |
| 02/17/2011 | WO2011018582A2 Floating microgranules |
| 02/17/2011 | WO2011018532A2 Steroid solvates |
| 02/17/2011 | WO2011018531A1 Dry powder inhaler formulations |
| 02/17/2011 | WO2011018522A1 Storage-stable formulation of paracetamol in aqueous solution |
| 02/17/2011 | WO2011018504A2 Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| 02/17/2011 | WO2011018482A1 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate |
| 02/17/2011 | WO2011018480A1 Pharmaceutical composition including a dha ester to be parenterally administered |
| 02/17/2011 | WO2011018474A1 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein |
| 02/17/2011 | WO2011018246A2 Controlled release paliperidone composition |
| 02/17/2011 | WO2011018185A2 Pharmaceutical tablet comprising rosuvastatin calcium |
| 02/17/2011 | WO2011017909A1 Pharmaceutical solution of cetirizine hydrochloride |
| 02/17/2011 | WO2011017903A1 Umbilical region treat device |
| 02/17/2011 | WO2011017835A1 Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding |
| 02/17/2011 | WO2010143074A3 Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor |
| 02/17/2011 | WO2010134097A3 Pharmaceutical composition of olanzapine and process for their preparation |
| 02/17/2011 | WO2010127206A3 Intraocular bioactive agent delivery compositon including a molecular partitioning system |
| 02/17/2011 | WO2010124004A3 Nanocarrier therapy for treating invasive tumors |
| 02/17/2011 | WO2010123845A3 Siderophore conjugate immunogenic compositions and vaccines |
| 02/17/2011 | WO2010123584A9 Method for transdermal iontophoretic delivery of chelated agents |
| 02/17/2011 | WO2010118339A3 Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability |
| 02/17/2011 | WO2010111565A3 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 02/17/2011 | WO2010042701A3 Corticosteroid compositions for use in treating diseases of the upper and lower airway passages |
| 02/17/2011 | WO2010007604A3 Inhalable microparticles, and methods for the production thereof |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110040057 Ligand-coupled initiator polymers and methods of use |
| 02/17/2011 | US20110039949 Pet food product and method of manufacture |
| 02/17/2011 | US20110039929 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 02/17/2011 | US20110039876 Solution formulations of sirolimus and its analogs for cad treatment |
| 02/17/2011 | US20110039805 Method for treating meibomian gland disease |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110038942 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
| 02/17/2011 | US20110038941 Lipid Nanoparticle Compositions and Methods of Making and Using the Same |
| 02/17/2011 | US20110038940 Pulverulent composition and a process for preparing the same |
| 02/17/2011 | US20110038939 Therapeutic stable nanoparticles |
| 02/17/2011 | US20110038938 Compositions for tissue augmentation |
| 02/17/2011 | US20110038937 Methods for delivering siRNA via Ionthophoresis |
| 02/17/2011 | US20110038936 System and method for electrospun drug loaded biodegradable chemotherapy applications |
| 02/17/2011 | US20110038935 Antibodies against influenza virus and methods of use thereof |
| 02/17/2011 | US20110038934 Pharmaceutical composition with atorvastatin active ingredient |
| 02/17/2011 | US20110038933 Stable benzimidazole formulation |
| 02/17/2011 | US20110038932 Methods and materials for treating conditions associated with metabolic disorders |
| 02/17/2011 | US20110038931 Composite preparation |
| 02/17/2011 | US20110038930 Hot-melt extruded pharmaceutical dosage form |
| 02/17/2011 | US20110038929 Oral care pet product and method |
| 02/17/2011 | US20110038928 Orally disintegrating tablets of zolmitriptan |
| 02/17/2011 | US20110038927 Controlled release hydrocodone formulations |
| 02/17/2011 | US20110038926 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/17/2011 | US20110038925 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | US20110038924 Osteoarthritis gene therapy |
| 02/17/2011 | US20110038923 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
| 02/17/2011 | US20110038922 Compounds for treating or preventing amine oxidase related diseases or disorders |
| 02/17/2011 | US20110038921 Methods and compositions for temporal release of agents from a biodegradable scaffold |
| 02/17/2011 | US20110038920 Wound healing compositions and treatments |
| 02/17/2011 | US20110038919 Textile materials with adhesive and methods for use thereof |
| 02/17/2011 | US20110038918 Composition For Transdermal Delivery of Fentanyl |
| 02/17/2011 | US20110038917 Therapeutic compositions and methods for treating gram-negative bacterial infections |
| 02/17/2011 | US20110038916 Sanitizers |
| 02/17/2011 | US20110038915 Chewing Gum Formula for Enhancing Psycho-Spirituality |
| 02/17/2011 | US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 02/17/2011 | US20110038910 Anti-infective antimicrobial-containing biomaterials |
| 02/17/2011 | US20110038908 Formulations and methods employing anhydrous disinfectant |
| 02/17/2011 | US20110038906 Aloe powder, aloe juice, and method for producing the same |
| 02/17/2011 | US20110038904 Gel Product |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038901 Method for Gentle Mechanical Generation of Finely Dispersed Micro-/Nano-Emulsions with Narrow Particle Size Distribution and Device for Carrying Out Said Method |
| 02/17/2011 | US20110038900 Nanoparticles for use in pharmaceutical compositions |
| 02/17/2011 | US20110038899 Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents |
| 02/17/2011 | US20110038898 Dissolution properties of drug products containing olmesartan medoxomil |